Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on EquityReturn on Sales

Summit Therapeutics (SMMT) Return on Invested Capital (2017 - 2020)

Historic Return on Invested Capital for Summit Therapeutics (SMMT) over the last 4 years, with Q1 2020 value amounting to 0.54%.

  • Summit Therapeutics' Return on Invested Capital changed N/A to 0.54% in Q1 2020 from the same period last year, while for Mar 2020 it was 0.54%, marking a year-over-year change of. This contributed to the annual value of 0.64% for FY2020, which is 2200.0% down from last year.
  • Summit Therapeutics' Return on Invested Capital amounted to 0.54% in Q1 2020.
  • Over the past 5 years, Summit Therapeutics' Return on Invested Capital peaked at 88844148.39% during Q1 2018, and registered a low of 164134102.21% during Q4 2017.
  • Over the past 4 years, Summit Therapeutics' median Return on Invested Capital value was 0.1% (recorded in 2019), while the average stood at 1420377.02%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first skyrocketed by 2000000000bps in 2018, then crashed by 2000000000bps in 2019.
  • Over the past 4 years, Summit Therapeutics' Return on Invested Capital (Quarter) stood at 164134102.21% in 2017, then soared by 100bps to 0.24% in 2018, then plummeted by -304bps to 0.96% in 2019, then skyrocketed by 44bps to 0.54% in 2020.
  • Its Return on Invested Capital was 0.54% in Q1 2020, compared to 0.96% in Q3 2019 and 0.03% in Q1 2019.